title: Sepsis-associated encephalopathy.
abstract: Sepsis-associated encephalopathy (SAE) is defined as a diffuse or multifocal cerebral dysfunction induced by the systemic response to the infection without clinical or laboratory evidence of direct brain infection. Its pathogenesis is multifactorial. SAE generally occurs early during severe sepsis and precedes multiple-organ failure. The most common clinical feature of SAE is the consciousness alteration which ranges from mildly reduced awareness to unresponsiveness and coma. Diagnosis of SAE is primarily clinical and depends on the exclusion of other possible causes of brain deterioration. Electroencephalography (EEG) is almost sensitive, but it is not specific for SAE. Computed Tomography (CT) head scan generally is negative in case of SAE, while Magnetic Resonance Imaging (MRI) can show brain abnormalities in case of SAE, but they are not specific for this condition. Somatosensitive Evoked Potentials (SEPs) are sensitive markers of developing cerebral dysfunction in sepsis. Cerebrospinal fluid (CBF) analysis is generally normal, a part an inconstant elevation of proteins concentration. S100B and NSE have been proposed like biomarkers for diagnosis of SAE, but the existing data are controversial. SAE is reversible even if survivors of severe sepsis have often long lasting or irreversible cognitive and behavioral sequel; however the presence of SAE can have a negative influence on survival. A specific therapy of SAE does not exist and the outcome depends on a prompt and appropriate treatment of sepsis as whole.
authors.affiliation: Dipartimento di Scienze Chirurgiche, Anestesiologiche Rianimatorie e dell'Emergenza, Università degli Studi di Napoli "Federico II".
authors.forename: Simona
authors.initials: S
authors.lastname: Cotena
authors.forename: Ornella
authors.initials: O
authors.lastname: Piazza
keywords: S100B; Sepsis-associated encephalopathy; blood brain barrier; brain edema
references.citation: J Neurochem. 2005 Sep;94(6):1546-58
references.pmid: 16000148
references.citation: Crit Care Med. 2006 Jul;34(7):1967-74
references.pmid: 16607230
references.citation: J Gerontol A Biol Sci Med Sci. 2006 Dec;61(12):1294-9
references.pmid: 17234823
references.citation: Minerva Anestesiol. 2005 Jan-Feb;71(1-2):39-52
references.pmid: 15711505
references.citation: AJNR Am J Neuroradiol. 2006 Nov-Dec;27(10):2179-90
references.pmid: 17110690
references.citation: Crit Care. 2007;11(6):R123
references.pmid: 18045492
references.citation: Intensive Care Med. 2003 May;29(5):801-7
references.pmid: 12577145
references.citation: Intensive Care Med. 2007 May;33(5):798-806
references.pmid: 17377766
references.citation: Clinics (Sao Paulo). 2011;66(10):1825-31
references.pmid: 22012058
references.citation: Crit Care. 2009;13(2):135
references.pmid: 19439043
references.citation: Crit Care. 2010;14(2):R50
references.pmid: 20356365
references.citation: Intensive Care Med. 2007 Jun;33(6):941-50
references.pmid: 17410344
references.citation: Anesth Analg. 2005 Nov;101(5):1465-1469
references.pmid: 16244012
references.citation: Crit Care. 2005 Feb;9(1):R18-23
references.pmid: 15693962
references.citation: Crit Care. 2010;14(2):R54
references.pmid: 20374626
references.citation: Neuroreport. 2011 Dec 21;22(18):959-64
references.pmid: 22027512
references.citation: Crit Care Med. 2002 May;30(5):1136-9
references.pmid: 12006815
references.citation: Crit Care. 2009;13(1):R12
references.pmid: 19196477
references.citation: Crit Care. 2010;14(1):R16
references.pmid: 20149231
references.citation: Crit Care. 2005 Feb;9(1):37-44
references.pmid: 15693982
references.citation: Neurochem Res. 2009 Jul;34(7):1289-92
references.pmid: 19132530
references.citation: Crit Care Med. 1992 Jun;20(6):864-74
references.pmid: 1597042
references.citation: Br J Anaesth. 2007 Oct;99(4):518-21
references.pmid: 17650519
references.citation: Can J Neurol Sci. 2003 May;30(2):98-105
references.pmid: 12774948
references.citation: Mayo Clin Proc. 2010 May;85(5):427-32
references.pmid: 20435835